Affigen Competitors and Similar CompaniesClear all
Affigen's competitors and similar companies include Kyowa Kirin and 3sbio.
 Kyowa Kirin Kyowa Kirin (formerly Kyowa Hakko Kirin) is a pharmaceutical company focused on the areas of oncology, nephrology, immunology, and the central nervous system. | |||
Founding Date | Founding Date 2016 | Founding Date 2008 | Founding Date 1993 |
Type | Type Private | Type Public | Type Public |
Tags | |||
Locations | Locations Houston, US HQ | Locations Shenyang, CN HQ | |
Employees | Employees 2 | Employees 5,669 | Employees 5,577 |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) ¥496.8b (FY, 2025) | Revenue (est.) ¥17.7b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods ¥114.3b (FY, 2025) | Cost of goods ¥818m (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit ¥383.4b (FY, 2025) | Gross profit ¥17b (FY, 2025) |
Net income | Net income N/A | Net income ¥67b (FY, 2025) | Net income ¥9.1b (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 17m | Total funding raised N/A | Total funding raised $ 15.2m |
For sources of this data, please see the company profile
View Company Profiles
Kyowa Kirin
HQ
Tokyo, JP
Employees
5,669
Kyowa Kirin (formerly Kyowa Hakko Kirin) is a pharmaceutical company focused on the areas of oncology, nephrology, immunology, and the central nervous system.
View company
3sbio
HQ
Shenyang, CN
Employees
5,577
3sbio (三生制药集团) is a company that develops biopharmaceuticals.
View company